The University of the Pacific is committed to advancements in hearing health, including innovative technologies like Lenire®—a clinically studied, FDA-cleared device designed to alleviate tinnitus symptoms.
How Lenire Works
Lenire uses bimodal neuromodulation, stimulating two sensory pathways simultaneously. Patients listen to customized sounds via headphones while receiving gentle electrical pulses on the tongue. This dual stimulation helps retrain the brain to reduce focus on tinnitus signals.
Clinical Results
In trials with over 600 participants, 95% reported symptom improvement after 12 weeks, and 91% sustained benefits one-year post-treatment.
While Lenire is not currently offered at the University of the Pacific, our audiology experts are dedicated to educating patients about emerging therapies. If you’re interested in exploring tinnitus solutions, consult your healthcare provider to discuss whether Lenire may be suitable for you.